A recent study conducted by NYU Langone, with funding from the National Institutes of Health and the National Institute on Drug Abuse, reveals the alarming dominance of fentanyl in the illegal drug market in the United States. This transition has occurred rapidly.
Data from law enforcement seizures indicates a staggering 1700% increase in illicit fentanyl seizures between 2017 and 2023.
In 2023, fentanyl pills accounted for almost half (49%) of fentanyl seizures, a significant rise from 10% in 2017. The majority of these seizures (85%) are concentrated in the western region of the country.
Lead researcher Dr. Joseph Palamar expressed that while the statistics are concerning, they align with current trends. He noted, “A few years ago, fentanyl was primarily in powder form. However, it began infiltrating the heroin supply, leading to the emergence of fentanyl-laced pills, especially in the western region, revolutionizing the consumption of fentanyl.”
Related stories:
Palamar emphasized that the introduction of fentanyl in pill form has altered the accessibility of the drug. Pills offer a more convenient and discrete method of consumption compared to injection. Moreover, due to their resemblance to legitimate medication, individuals may unknowingly ingest fentanyl, increasing the risk of overdose.
Rob Sullivan, a leader in drug detox programs in northwestern Washington state, highlighted the challenges posed by fentanyl detoxification. He mentioned the prolonged detox duration, difficulties in completion, and instances of individuals detoxing without awareness of fentanyl intake.
Palamar advocated for heightened drug prevention efforts in light of these findings, emphasizing the importance of educating individuals, particularly those who have not encountered fentanyl before, on its dangers. He expressed concern over the potential initiation of fentanyl use and unintentional exposure, particularly among young individuals.
